Position of γ-Chain Carboxy-Terminal Regions in Fibrinogen/Fibrin Cross-Linking Mixtures
Biochemistry
2000
- 51Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage51
- Downloads48
- Abstract Views3
Article Description
There are conflicting ideas regarding the location of the carboxyl-terminal regions of cross-linked γ-chain dimers in double-stranded fibrin fibrils. Some investigators believe that the chains are always oriented longitudinally along each fibril strand and traverse the contacting ends of abutting fibrin D domains (“DD-long” cross-linking). Other investigations have indicated instead that the chains are situated transversely between adjacent D domains in opposing fibril strands (transverse cross-linking). To distinguish between these two possibilities, the γ dimer composition of factor XIIIa-cross-linked fibrin/fibrinogen complexes that had been formed through noncovalent D/E interactions between fibrinogen D domains and fibrin E domains was examined. Two factor XIIIa-mediated cross-linking conditions were employed. In the first, fibrin/fibrinogen complexes were formed between 125I-labeled fibrinogen 2 (“peak 2” fibrinogen), each heterodimeric molecule containing one γA and one larger γ‘ chain, and nonlabeled fibrin 1 molecules (“peak 1” fibrin), each containing two γA chains. If DD-long cross-linking occurred, 125I-labeled γA−γA, γA−γ‘, and γ‘−γ‘dimers in a 1:2:1 ratio would result. Transverse cross-linking would yield a 1:1 mixture of 125I-labeled γA−γA and γA−γ‘ dimers, without any γ‘−γ‘ dimers. Autoradiographic analyses of reduced SDS−PAGE gels from protocol 1 revealed 125I-labeled γA−γA and γA−γ‘ dimers at a ratio of ∼1:1. No labeled γ‘−γ‘ dimers were detected. Protocol 2 used a converse mixture, 125I-fibrin 2 and nonlabeled fibrinogen 1. DD-long cross-linking of this mixture would yield only nonradioactive γA−γA dimers, whereas transverse cross-linking would yield a 1:1 mixture of 125I-labeled γA−γA and γA−γ‘ dimers. Autoradiographic analyses of this mixture yielded 125I-labeled γA−γA and γA−γ‘ dimers in a 1:1 ratio. These findings provide no evidence that longitudinal (DD-long) γ chain positioning occurs in cross-linked fibrin and indicate instead that most, if not all, γ-chain positioning in an assembled fibrin polymer is transverse.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know